• Bishop, J.F., McGrath, K., Wolf, M.M., Matthews, J.P., De Luise, T., Holdsworth, R., Yuen, K., Veale, M., Whiteside, M.G. & Cooper, I.A. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383387.
  • Carrick, D.M., Norris, P.J., Endres, R.O., Pandey, S., Kleinman, S.H., Wright, D., Sun, Y. & Busch, M.P.; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II. (2011) Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion, 51, 20922101.
  • Doughty, H.A., Murphy, M.F., Metcalfe, P., Rohatiner, A.Z., Lister, T.A. & Waters, A.H. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sanguinis, 66, 200205.
  • Hod, E. & Schwartz, J. (2010) Platelet transfusion refractoriness. British Journal of Haematology, 142, 348360.
  • Kohl, M. (2012) MKmisc: Miscellaneous functions from M. Kohl. R package version 0.92.
  • Legler, T.J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W. & Köhler, M. (1997) Frequency and causes of refractoriness in multiply transfused patients. Annals of Hematology, 74, 185189.
  • Pavenski, K., Freedman, J. & Semple, J.W. (2012) HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention, and management. Tissue Antigens, 79, 237245.
  • Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.C. & Müller, M. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12, 77.
  • Slichter, S.J., Davis, K., Enright, H., Braine, H., Gernsheimer, T., Kao, K.J., Kickler, T., Lee, E., McFarland, J., McCullough, J., Rodey, G., Schiffer, C.A. & Woodson, R. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood, 105, 41064114.
  • Stanworth, S.J., Estcourt, L., Powter, G., Kahan, B.C., Dyer, C., Bakrania, L., Llewelyn, C., Choo, L., Bielby, L., Norfolk, D., Wood, E.M. & Murphy, M.F. (2012) The effect of a no-prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe tthrombocytopenia (TOPPS trial). A randomized controlled, non-inferiority trial. Blood (ASH Annual Meeting Abstracts), 120, 1.
  • The Trial to Reduce Alloimmunization to Platelets Study Group. (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The New England Journal of Medicine, 337, 18611869.